Back to search

Article

Exploratory Bayesian Synthesis of Targeted Agents Combined With Immune Checkpoint Inhibitors in Advanced Non–Small Cell Lung Cancer: A Network Meta-analysis of Single-Arm Studies

2026-06-01

Abstract excerpt

<title>Abstract</title> <p>Background: Combining targeted therapies with immune checkpoint inhibitors (ICIs) represents a promising strategy for the treatment of advanced non-small cell lung cancer (NSCLC), particularly in molecularly defined subgroups. However, the absence of randomized head-to-head trials comparing different targeted–immunotherapy combinations limits definitive conclusions about their relative...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d24b4c38-6c7b-5b67-93d6-c008f88e3b0b
DOI
10.21203/rs.3.rs-9670095/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploratory Bayesian Synthesis of Targeted Agents Combined With Immune Checkpoint Inhibitors in Advanced Non–Small Cell Lung Cancer: A Network Meta-analysis of Single-Arm StudiesDOI 10.21203/rs.3.rs-9670095/v1
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis.Semantic proximity
Comparative Safety of Immune Checkpoint Inhibitors and Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-AnalysisSemantic proximity
Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.Semantic proximity
Efficacy and safety of adjuvant EGFR TKI alone and in combination with chemotherapy for resected EGFR mutation-positive non-small cell lung cancer: A Bayesian network meta-analysis.Semantic proximity
The efficacy and safety of immune checkpoint inhibitors for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy: A systematic review and network meta-analysis.Semantic proximity
Identifying optimal first-line immune checkpoint inhibitors based regiments for advanced non-small cell lung cancer without oncogenic driver mutations: A systematic review and network meta-analysis.Semantic proximity
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with KRAS mutations: A network meta-analysis.Semantic proximity
Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in advanced non-small cell lung cancer: A systematic review of randomized controlled trialsSemantic proximity
Efficacy and safety of immune checkpoint inhibitors for EGFR mutated non-small cell lung cancer: a network meta-analysis.Semantic proximity
Immunotherapy for TKI-resistant, EGFR L858R-mutated non-small cell lung cancer: a systematic review and meta-analysis of randomized and single-arm studies.Semantic proximity
Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysisSemantic proximity
Efficacy and Safety of Immuno-based Therapy Versus Standard of Care in Extensive-stage Small-Cell Lung Cancer: An Updated Meta-analysis of Randomized Clinical TrialsSemantic proximity
Select a neighboring publication to make it the new centre.